239 related articles for article (PubMed ID: 9506530)
1. Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroids.
Wartenberg M; Frey C; Diedershagen H; Ritgen J; Hescheler J; Sauer H
Int J Cancer; 1998 Mar; 75(6):855-63. PubMed ID: 9506530
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin distribution in multicellular prostate cancer spheroids evaluated by confocal laser scanning microscopy and the "optical probe technique".
Wartenberg M; Hescheler J; Acker H; Diedershagen H; Sauer H
Cytometry; 1998 Feb; 31(2):137-45. PubMed ID: 9482283
[TBL] [Abstract][Full Text] [Related]
3. Redox regulation of P-glycoprotein-mediated multidrug resistance in multicellular prostate tumor spheroids.
Wartenberg M; Fischer K; Hescheler J; Sauer H
Int J Cancer; 2000 Jan; 85(2):267-74. PubMed ID: 10629088
[TBL] [Abstract][Full Text] [Related]
4. Induction of cell death by Doxorubicin in multicellular spheroids as studied by confocal laser scanning microscopy.
Wartenberg M; Acker H
Anticancer Res; 1996; 16(2):573-9. PubMed ID: 8687100
[TBL] [Abstract][Full Text] [Related]
5. Swelling-activated chloride channels in multidrug-sensitive and -resistant cells.
Ehring GR; Osipchuk YV; Cahalan MD
J Gen Physiol; 1994 Dec; 104(6):1129-61. PubMed ID: 7699367
[TBL] [Abstract][Full Text] [Related]
6. Partial circumvention of P-glycoprotein-mediated multidrug resistance by doxorubicin-14-O-hemiadipate.
Leontieva OV; Preobrazhenskaya MN; Bernacki RJ
Invest New Drugs; 2002 Feb; 20(1):35-48. PubMed ID: 12003193
[TBL] [Abstract][Full Text] [Related]
7. The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines.
Consoli U; Priebe W; Ling YH; Mahadevia R; Griffin M; Zhao S; Perez-Soler R; Andreeff M
Blood; 1996 Jul; 88(2):633-44. PubMed ID: 8695811
[TBL] [Abstract][Full Text] [Related]
8. Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity.
Jonsson O; Behnam-Motlagh P; Persson M; Henriksson R; Grankvist K
Biochem Pharmacol; 1999 Dec; 58(11):1801-6. PubMed ID: 10571255
[TBL] [Abstract][Full Text] [Related]
9. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
[TBL] [Abstract][Full Text] [Related]
10. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-Induced hyperthermia increases cellular uptake and cytotoxicity of P-glycoprotein substrates in multi-drug resistant cells.
Liu Y; Cho CW; Yan X; Henthorn TK; Lillehei KO; Cobb WN; Ng KY
Pharm Res; 2001 Sep; 18(9):1255-61. PubMed ID: 11683237
[TBL] [Abstract][Full Text] [Related]
13. Low-level doxorubicin resistance in P-glycoprotein-negative human pancreatic tumour PSN1/ADR cells implicates a brefeldin A-sensitive mechanism of drug extrusion.
Verovski VN; Van den Berge DL; Delvaeye MM; Scheper RJ; De Neve WJ; Storme GA
Br J Cancer; 1996 Mar; 73(5):596-602. PubMed ID: 8605092
[TBL] [Abstract][Full Text] [Related]
14. Reversal of resistance against doxorubicin by a newly developed compound, oxalyl bis(N-phenyl)hydroxamic acid in vitro.
Choudhuri SK; Chatterjee A
Anticancer Drugs; 1998 Oct; 9(9):825-32. PubMed ID: 9840730
[TBL] [Abstract][Full Text] [Related]
15. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line.
Toffoli G; Corona G; Gigante M; Boiocchi M
Eur J Cancer; 1996 Aug; 32A(9):1591-7. PubMed ID: 8911123
[TBL] [Abstract][Full Text] [Related]
17. Resistance to verapamil sensitization of multidrug-resistant cells grown as multicellular spheroids.
Sakata K; Kwok TT; Gordon GR; Waleh NS; Sutherland RM
Int J Cancer; 1994 Oct; 59(2):282-6. PubMed ID: 7927930
[TBL] [Abstract][Full Text] [Related]
18. Effect of S9788, cyclosporin A and verapamil on intracellular distribution of THP-doxorubicin in multidrug-resistant K562 tumor cells, as studied by laser confocal microspectrofluorometry.
Sebille S; Morjani H; Poullain MG; Manfait M
Anticancer Res; 1994; 14(6A):2389-93. PubMed ID: 7825978
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity.
Tang J; Zhang L; Gao H; Liu Y; Zhang Q; Ran R; Zhang Z; He Q
Drug Deliv; 2016 May; 23(4):1130-43. PubMed ID: 25491241
[TBL] [Abstract][Full Text] [Related]
20. Hypotonic Ca2+ signaling and volume regulation in proliferating and quiescent cells from multicellular spheroids.
Sauer H; Ritgen J; Hescheler J; Wartenberg M
J Cell Physiol; 1998 May; 175(2):129-40. PubMed ID: 9525471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
